期刊文献+

Antifungal activity of ibuprofen against aspergillus species and its interaction with common antifungal drugs

Antifungal activity of ibuprofen against aspergillus species and its interaction with common antifungal drugs
原文传递
导出
摘要 Background The incidence of invasive aspergillosis (IA) has increased in frequency in immunocompromised patients with a variety of diseases. The poor prognosis might be due to limited treatment option. This study aimed to evaluate antifungal activity of ibuprofen against clinical isolates of aspergillus species, as well as its interaction with azoles or with amphotericin B or with micafungin. Methods Antifungal activity of ibuprofen against 10 strains of Aspergillus fumigatus, Aspergillus flavus, and Aspergillus terreus were tested with both disk diffusion assay and standard broth microdilution method. To determine whether ibuprofen combined with itraconazole, voriconazole, amphotericin B, or micafungin had interactive effects on aspergillus spp., we used both disk diffusion assay and Chequerboard method. Results As for disk diffusion method, ibuprofen produced a zone of growth inhibition with diameters of (20.1±3.9) mm at 48 hours of incubation. As for broth microdilution method, the minimal inhibitory concentration (MIC) ranges of ibuprofen against aspergillus spp. were 1000-2000 μg/ml, and the minimal fungicidal concentration (MFC) ranges of that was 2000-8000 μg/ml. For 2 of 5 isolates, when ibuprofen combined with itraconazole or voriconazole, the zones of growth inhibition were larger than those of the individual drug. The results of Chequerboard method showed that fractional inhibitory concentration index (FICI) ranges were 1.125-2.500. Conclusions Ibuprofen is active against aspergillus spp.. And ibuprofen does not affect the in vitro activity of itraconazole, voriconazole, amphotericin B or micafungin against aspergillus spp. Background The incidence of invasive aspergillosis (IA) has increased in frequency in immunocompromised patients with a variety of diseases. The poor prognosis might be due to limited treatment option. This study aimed to evaluate antifungal activity of ibuprofen against clinical isolates of aspergillus species, as well as its interaction with azoles or with amphotericin B or with micafungin. Methods Antifungal activity of ibuprofen against 10 strains of Aspergillus fumigatus, Aspergillus flavus, and Aspergillus terreus were tested with both disk diffusion assay and standard broth microdilution method. To determine whether ibuprofen combined with itraconazole, voriconazole, amphotericin B, or micafungin had interactive effects on aspergillus spp., we used both disk diffusion assay and Chequerboard method. Results As for disk diffusion method, ibuprofen produced a zone of growth inhibition with diameters of (20.1±3.9) mm at 48 hours of incubation. As for broth microdilution method, the minimal inhibitory concentration (MIC) ranges of ibuprofen against aspergillus spp. were 1000-2000 μg/ml, and the minimal fungicidal concentration (MFC) ranges of that was 2000-8000 μg/ml. For 2 of 5 isolates, when ibuprofen combined with itraconazole or voriconazole, the zones of growth inhibition were larger than those of the individual drug. The results of Chequerboard method showed that fractional inhibitory concentration index (FICI) ranges were 1.125-2.500. Conclusions Ibuprofen is active against aspergillus spp.. And ibuprofen does not affect the in vitro activity of itraconazole, voriconazole, amphotericin B or micafungin against aspergillus spp.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第19期2701-2705,共5页 中华医学杂志(英文版)
基金 This work was supported by grants from the National Natural Science Foundation of China (No. 30970131) and the Key Project of Chinese Ministry of Education (No. 107002).
关键词 aspergillus spp. IBUPROFEN antifungal susceptibility drug interaction aspergillus spp. ibuprofen antifungal susceptibility drug interaction
  • 相关文献

参考文献20

  • 1Erjavec Z,Kluin-Nelemans H,Verweij PE.Trends in invasive fungal infections,with emphasis on invasive aspergillosis.Clin Microbiol Infect 2009; 15:625-633. 被引量:1
  • 2Walsh TJ,Anaissie EJ,Denning DW,Herbrecht R,Kontoyiannis DP,Marr KA,et al.Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America.Clin Infect Dis 2008; 46:327-360. 被引量:1
  • 3Benjamin DK Jr,Miller WC,Bayliff S,Martel L,Alexander KA,Martin PL.Infections diagnosed in the first year after pediatric stem cell transplantation.Pediatr Infect Dis J 2002;21:227-234. 被引量:1
  • 4Comet M,Fleury L,Maslo C,Bernard JF,Brücker G.Epidemiology of invasive aspergillosis in France:a six-year multicentric survey in the greater Paris area.J Hosp Infect 2002; 51:288-296. 被引量:1
  • 5Grow WB,Moreb JS,Roque D,Manion K,Leather H,Reddy V,et al.Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.Bone Marrow Transplant 2002; 29:15-19. 被引量:1
  • 6Patterson TF.Advances and challenges in management of invasive mycoses.Lancet 2005; 366:1013-1025. 被引量:1
  • 7Kontoyiannis DP,Bodey GP.Invasive aspergillosis in 2002:an update.Eur J Clin Microbiol Infect Dis 2002; 21:161-172. 被引量:1
  • 8Hersh EV,Moore PA,Ross GL.Over-the-counter analgesics and antipyretics:a critical assessment.Clin Ther 2000; 22:500-548. 被引量:1
  • 9Pina-Vaz C,Sansonetty F,Rodrigues AG,Martinez-DeOliveira J,Fonseca AF,M(a)rdh PA.Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species.J Med Microbiol 2000; 49:831-840. 被引量:1
  • 10Scott EM,Tariq VN,McCrory RM.Demonstration of synergy with fluconazole and either ibuprofen,sodium salicylate,or propylparaben against Candida albicans in vitro.Antimicrob Agents Chemother 1995; 39:2610-2614. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部